Stay updated on Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed on the page, replacing v3.3.1. This is a minor site update and does not alter study information.
    Difference
    0.0%
    Check dated 2025-12-01T16:29:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The Publications section now notes that items are auto-filled from PubMed and may not all be about the study, and the revision version is updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:10:18.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding status notice banner from the page; this banner did not affect the trial details, eligibility criteria, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:09:17.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No significant changes detected between the old and new screenshots of the Study Details page; the main sections appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:44:01.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T05:16:14.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Key additions provide updated results posting, date, and clarified trial design (three cohorts, eligibility, primary objective). The deletions remove an older version of the same trial description, replacing it with the newer, more detailed text.
    Difference
    70%
    Check dated 2025-09-28T02:49:50.000Z thumbnail image

Stay in the know with updates to Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.